Correlation Between Kiniksa Pharmaceuticals and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Kiniksa Pharmaceuticals and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiniksa Pharmaceuticals and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiniksa Pharmaceuticals and Nuvectis Pharma, you can compare the effects of market volatilities on Kiniksa Pharmaceuticals and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiniksa Pharmaceuticals with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiniksa Pharmaceuticals and Nuvectis Pharma.
Diversification Opportunities for Kiniksa Pharmaceuticals and Nuvectis Pharma
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kiniksa and Nuvectis is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Kiniksa Pharmaceuticals and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Kiniksa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiniksa Pharmaceuticals are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Kiniksa Pharmaceuticals i.e., Kiniksa Pharmaceuticals and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Kiniksa Pharmaceuticals and Nuvectis Pharma
Given the investment horizon of 90 days Kiniksa Pharmaceuticals is expected to generate 2.76 times less return on investment than Nuvectis Pharma. But when comparing it to its historical volatility, Kiniksa Pharmaceuticals is 2.23 times less risky than Nuvectis Pharma. It trades about 0.03 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 696.00 in Nuvectis Pharma on November 3, 2024 and sell it today you would lose (20.00) from holding Nuvectis Pharma or give up 2.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Kiniksa Pharmaceuticals vs. Nuvectis Pharma
Performance |
| Timeline |
| Kiniksa Pharmaceuticals |
| Nuvectis Pharma |
Kiniksa Pharmaceuticals and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiniksa Pharmaceuticals and Nuvectis Pharma
The main advantage of trading using opposite Kiniksa Pharmaceuticals and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiniksa Pharmaceuticals position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Kiniksa Pharmaceuticals vs. Nuvalent | Kiniksa Pharmaceuticals vs. Ventyx Biosciences | Kiniksa Pharmaceuticals vs. Arcellx | Kiniksa Pharmaceuticals vs. Cullinan Oncology LLC |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |